Somatrem
Pharmaceutical drug
Somatrem, sold under the brand name Protropin, is an analogue of growth hormone (GH).
01Overview
Somatrem is a recombinant human growth hormone used for the treatment of short stature due to decreased or absent secretion of endogenous growth hormone.
Somatrem was first marketed under the brand name Protropin by Genentech in 1985. It differs from endogenous growth hormone by the addition of an extra methionine at the N-terminus.
Somatrem has largely been replaced by somatropin, marketed by several companies including by Genentech as the brand Nutropin.
Sources and credits
This article is adapted from the Wikipedia article “Somatrem”, written by its contributors and licensed under CC BY-SA 4.0. Fathomly has changed the layout, removed citation markers, navigation and maintenance notices, and adjusted punctuation. This adapted version is shared under the same license. For references, see the original article.
Fathomly is not affiliated with or endorsed by the Wikimedia Foundation. Spotted a problem? Tell us.